A coach in Singapore told me the same thing my doctor friend in Bangkok told me: the people who quit tirzepatide almost all quit between week 6 and week 10. The reason isn't the side effects you'd guess. It's the gap between when the discomfort peaks and when the visible results start showing up.
Most coverage is either too dismissive (\"just some nausea\") or too alarmist (\"brutal stomach issues forever\"). After watching a few hundred people start tirzepatide and semaglutide over the past year, here's the actual shape of the side effects most people get.
Eight US telehealth platforms scored against Panya's 11-signal rubric. Three routable (Ro, Calibrate, WW Clinic), one conditional (Found), four hold (Hims, Mochi, Henry, Eden). The April 30 FDA proposal closes the cheap-compounded-supply lane · this is the new map.
Five months after the FDA closed enforcement discretion on 503A and 503B compounded tirzepatide and semaglutide, the US compounded-GLP-1 landscape has consolidated, contracted, and fragmented. The April 30 scorecard recap captured the snapshot. This is what changed in the four weeks after.
Bangkok is the regional anchor for legitimately-supplied tirzepatide and semaglutide in Southeast Asia. Flight matrices, clinic-relationship cadence, cold-chain transit, customs personal-use rules per origin country, and the four-versus-twelve-week supply math.
Weekly read on what's actually in stock at the Bangkok premium hospitals and mid-tier clinics, with price changes since last digest, regulatory movements that affect supply, and the picking question for this week. New format, weekly cadence, BKK-anchored. Issue 1.
The semaglutide and tirzepatide effect on alcohol intake is real and well-documented. The mechanism is partly understood, the long-term safety data is thin, and the practical advice for users on the drug is more nuanced than 'one drink is fine.' What the 2026 SURMOUNT-OASIS and downstream trials add.
Side-by-side comparison of the three branded GLP-1 pens available in Bangkok in May 2026. Per-month USD pricing at premium hospitals and mid-tier clinics, supply state per medication, and the picking question once cost is on the table.
The four Bangkok premium hospitals scored on Panya's 11-signal rubric: Bumrungrad, Samitivej Sukhumvit, BNH, and BDMS Wellness Clinic. JCI accreditation, real GLP-1 menu depth, BDMS-group concentration, and how Thailand-resident expats actually pick.
Longevity clinics are prescribing tirzepatide and semaglutide at fractional doses for non-obese patients. Here is what the data supports, what it does not, and the risk-benefit tradeoff.
The three GLP-1 drugs that matter in 2026: semaglutide (Ozempic/Wegovy), tirzepatide (Mounjaro/Zepbound), and retatrutide (Lilly's triple-agonist). How they differ in mechanism, weight loss, side effects, and cost.
Same drug class, different receptor profile. Here is the honest comparison, without the marketing gloss.